BioSpace News Archive

Drug Development

Viralytics Ltd Presents Phase 2 Melanoma Extension Cohort Data, Updated CALM Study Survival And CAVATAK/Immune Checkpoint Combination Preclinical Data At 2015 European Cancer Congress

September 28, 2015
·
5 min read
Drug Development

Viralytics Ltd Initiates Clinical Trial Of CAVATAK In Combination With PD-1 Blocker Keytruda

September 28, 2015
·
4 min read
Business

Teijin Pharma To Collaborate With Peptidream In Peptide Discovery

September 28, 2015
·
1 min read
Business

Protectimmun Teams Up With Johnson & Johnson Innovation And Imperial College London Under A Research Funding Agreement

September 28, 2015
·
1 min read
Drug Development

Advanced Accelerator Applications Announces Positive Results From Phase 3 Study NETTER-1 Evaluating Lutathera In Patients With Advanced Midgut Neuroendocrine Tumors

September 28, 2015
·
8 min read
Pharm Country

European Symposia: Advanced Preclinical Models For Immunology, Oncology And Infectious Disease

September 28, 2015
·
2 min read
Business

Sequenom Updates Second Half 2015 Revenue Outlook

September 28, 2015
·
3 min read
Drug Development

AEterna Zentaris’ Zoptarelin Doxorubicin Meets Phase 2 Primary Endpoint In Men With Heavily Pretreated Castration And Taxane Resistant Prostate Cancer

September 28, 2015
·
5 min read
FDA

ClarVista HARMONI Receives CE Mark For Europe

September 28, 2015
·
3 min read
Drug Development

Array BioPharma, Inc. Release: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma

September 28, 2015
·
8 min read